Prophylactic Enoxaparin Dosing in Roux-en-Y Gastric Bypass Surgery Patients at St. Vincent Carmel

Comparing Angiomax to Heparin With Protamine in Patients Undergoing Cardiopulmonary Bypass (CPB)

NCT00079586 ·Status: COMPLETED ·Phase: PHASE3

Optimal Heparin Dosing Regimens for Cardiopulmonary Bypass

NCT00587444 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of Preoperative Antithrombin Supplementation in Patients Undergoing High-Risk Cardiopulmonary Bypass

NCT02037555 ·Status: COMPLETED ·Phase: PHASE2

Short-term Endothelin A Receptor Blockade in Patients With On-pump CABG

NCT01658410 ·Status: UNKNOWN ·Phase: PHASE2

Clinical Trial Comparing Heparin and Protamine Fixed and Titrated Doses in Cardiac Surgery With Cardiopulmonary Bypass

NCT01267487 ·Status: COMPLETED ·Phase: PHASE4

Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

NCT04045665 ·Status: RECRUITING ·Phase: PHASE3

Cardiac CAtheterization for Bypass Graft Patency Rate Optimization: the CABG-PRO Randomized-controlled Pilot Study

NCT01063491 ·Status: UNKNOWN ·Phase: PHASE3

The Effect of 6% Hydroxyethyl Starch 130/0.4 on Blood Loss and Coagulation in Patients Medicated With Antiplatelet Agents Prior to Off-Pump Coronary Bypass Graft Surgery

NCT01051206 ·Status: COMPLETED ·Phase: PHASE4

Comparing Angiomax to Heparin With Protamine Reversal in Patients OPCAB

NCT00073593 ·Status: COMPLETED ·Phase: PHASE3

A Pre- and Post- Coronary Artery Bypass Graft Implantation Disposed Application of Xenon

NCT01285271 ·Status: COMPLETED ·Phase: PHASE3

Heparin Based on Ideal Body Weight for Cardiopulmonary Bypass in Obese Patients

NCT02675647 ·Status: COMPLETED ·Phase: PHASE4

Management of Bleeding Following Cardiopulmonary Bypass

NCT00672516 ·Status: COMPLETED

Post Coronary Artery Bypass Graft (CABG) Study

NCT00000463 ·Status: COMPLETED ·Phase: PHASE3

Cardioprotective Effects of Endogenous Erythropoietin in Patients Undergoing Coronary Artery Bypass Surgery

NCT00854217 ·Status: COMPLETED ·Phase: NA

Retrospective Observational Study of Patients Who Have Undergone Coronary Artery Bypass Graft (CABG) and/or Cardiac Valve Surgery

NCT07009340 ·Status: ACTIVE_NOT_RECRUITING

Study of NU172 as Anticoagulation in Patients Undergoing Off-pump CABG Surgery

NCT00808964 ·Status: UNKNOWN ·Phase: PHASE2

Xenon in Off-pump Coronary Artery Bypass Graft Surgery

NCT01757106 ·Status: COMPLETED ·Phase: PHASE2

Fibrinogen and Bleeding After Cardiac Surgery

NCT00968045 ·Status: COMPLETED ·Phase: PHASE2

A Single Center Clinical Evaluation of Same Sitting Hybrid Revascularization: Robotic Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention for the Treatment of Coronary Artery Disease

NCT00928356 ·Status: COMPLETED ·Phase: NA

A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume

NCT00816023 ·Status: COMPLETED ·Phase: PHASE2

Does Prophylactic Coronary Artery Revascularization for High Risk Patients Reduce Long-term Risk of Mortality

NCT00032370 ·Status: COMPLETED ·Phase: NA

Biologically Modified Saphenous Vein Transplants for Improved CABG Outcomes

NCT01313533 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Prophylactic IABP in High-risk Patients Undergoing CABG

NCT01950130 ·Status: WITHDRAWN ·Phase: NA

Cell Salvage and Retrograde Autologous Priming

NCT04792814 ·Status: COMPLETED

The Epidemiology of Bleeding and Clotting in Patients Undergoing Heart Transplantation, Coronary Artery Bypass Graft Surgery,or Implantation of Left Ventricular Assist Devices

NCT01481012 ·Status: TERMINATED